221 related articles for article (PubMed ID: 35819097)
1. Monocytes subtypes from pleural effusion reveal biomarker candidates for the diagnosis of tuberculosis and malignancy.
Luo L; Deng S; Tang W; Hu X; Yin F; Ge H; Tang J; Liao Z; Feng J; Li X; Mo B
J Clin Lab Anal; 2022 Aug; 36(8):e24579. PubMed ID: 35819097
[TBL] [Abstract][Full Text] [Related]
2. Anaphylatoxins Enhance Recruitment of Nonclassical Monocytes via Chemokines Produced by Pleural Mesothelial Cells in Tuberculous Pleural Effusion.
Luo L; Li X; Hu X; Hu C; Tang W; Deng S; Feng J
Am J Respir Cell Mol Biol; 2019 Apr; 60(4):454-464. PubMed ID: 30422670
[TBL] [Abstract][Full Text] [Related]
3. [Level of soluble programmed death ligand 1 in pleural effusion and peripheral blood of patients with tuberculous pleural effusion and its clinical implications].
Pan X; Xing Y; Shi M; Zhou T; Qian B; Chen Y
Zhonghua Yi Xue Za Zhi; 2014 May; 94(20):1543-6. PubMed ID: 25146741
[TBL] [Abstract][Full Text] [Related]
4. Combined detections of interleukin 27, interferon-γ, and adenosine deaminase in pleural effusion for diagnosis of tuberculous pleurisy.
Wu YB; Ye ZJ; Qin SM; Wu C; Chen YQ; Shi HZ
Chin Med J (Engl); 2013; 126(17):3215-21. PubMed ID: 24033939
[TBL] [Abstract][Full Text] [Related]
5. High IL-35 pleural expression in patients with tuberculous pleural effusion.
Dong X; Yang J
Med Sci Monit; 2015 May; 21():1261-8. PubMed ID: 25935866
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Accuracy of Interleukin-27 between Tuberculous Pleural Effusion and Malignant Pleural Effusion: A Meta-Analysis.
Liu Q; Yu YX; Wang XJ; Wang Z; Wang Z
Respiration; 2018; 95(6):469-477. PubMed ID: 29539604
[TBL] [Abstract][Full Text] [Related]
7. Influence of age on the diagnostic accuracy of soluble biomarkers for tuberculous pleural effusion: a post hoc analysis.
Jiang CG; Wang W; Zhou Q; Wu XZ; Wang XJ; Wang Z; Zhai K; Shi HZ
BMC Pulm Med; 2020 Jun; 20(1):178. PubMed ID: 32571326
[TBL] [Abstract][Full Text] [Related]
8. Clinical value of haptoglobin and soluble CD163 testing for the differential diagnosis of tuberculous and malignant pleural effusions.
Gao J; Song L; Li D; Peng L; Ding H
Medicine (Baltimore); 2019 Oct; 98(42):e17416. PubMed ID: 31626097
[TBL] [Abstract][Full Text] [Related]
9. Differential diagnosis of tuberculous and malignant pleural effusions: comparison of the Th1/Th2 cytokine panel, tumor marker panel and chemistry panel.
Zhang J; Chen Y; He G; Jiang X; Chen P; Ouyang J
Scand J Clin Lab Invest; 2020 Jul; 80(4):265-270. PubMed ID: 32108543
[TBL] [Abstract][Full Text] [Related]
10. Novel biomarker analysis of pleural effusion enhances differentiation of tuberculous from malignant pleural effusion.
Chen KY; Feng PH; Chang CC; Chen TT; Chuang HC; Lee CN; Su CL; Lin LY; Lee KY
Int J Gen Med; 2016; 9():183-9. PubMed ID: 27354819
[TBL] [Abstract][Full Text] [Related]
11. Pleural IFN-γ release assay combined with biomarkers distinguished effectively tuberculosis from malignant pleural effusion.
Tang Y; Zhang J; Huang H; He X; Zhang J; Ou M; Li G; Zeng C; Ye T; Ren L; Liu Y; Zhang G
BMC Infect Dis; 2019 Jan; 19(1):55. PubMed ID: 30651075
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic role of interleukin -33 in the differentiation of pleural effusions especially tuberculous and malignant effusions.
Al-Aarag AH; Kamel MH; Abdelgawad ER; Abo-Youssef SM; Moussa HH; Elnaggar ME; Hendy RM; Diab KA
BMC Pulm Med; 2019 Jun; 19(1):114. PubMed ID: 31238901
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic values of different cytokines in identifying tuberculous pleural effusion.
Nguyen MH; Dao QM; Bui TTH; Le VHT
Trop Biomed; 2020 Jun; 37(2):372-378. PubMed ID: 33612806
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 32 as a Potential Marker for Diagnosis of Tuberculous Pleural Effusion.
Du J; Shao MM; Yi FS; Huang ZY; Qiao X; Chen QY; Shi HZ; Zhai K
Microbiol Spectr; 2022 Aug; 10(4):e0255321. PubMed ID: 35880892
[TBL] [Abstract][Full Text] [Related]
15. S100A2: A potential biomarker to differentiate malignant from tuberculous pleural effusion.
Wang T; Wang N; Zhang L; Liu Y; Thakur A
Indian J Cancer; 2021; 58(2):241-247. PubMed ID: 33402562
[TBL] [Abstract][Full Text] [Related]
16. Recruitment of IL-1β-producing intermediate monocytes enhanced by C5a contributes to the development of malignant pleural effusion.
Luo L; Deng S; Tang W; Hu X; Yin F; Ge H; Tang J; Liao Z; Li X; Feng J
Thorac Cancer; 2022 Mar; 13(6):811-823. PubMed ID: 35137541
[TBL] [Abstract][Full Text] [Related]
17. T Helper Cell Subsets in the Pleural Fluid of Tuberculous Patients Differentiate Patients With Non-Tuberculous Pleural Effusions.
Roofchayee ND; Adcock IM; Marjani M; Dezfuli NK; Varahram M; Garssen J; Mortaz E
Front Immunol; 2021; 12():780453. PubMed ID: 34925358
[TBL] [Abstract][Full Text] [Related]
18. Cell origins and diagnostic accuracy of interleukin 27 in pleural effusions.
Yang WB; Liang QL; Ye ZJ; Niu CM; Ma WL; Xiong XZ; Du RH; Zhou Q; Zhang JC; Shi HZ
PLoS One; 2012; 7(7):e40450. PubMed ID: 22792330
[TBL] [Abstract][Full Text] [Related]
19. Anaphylatoxins orchestrate Th17 response via interactions between CD16+ monocytes and pleural mesothelial cells in tuberculous pleural effusion.
Deng S; Hu X; Luo L; Tang W; Jiang Y; Yin F; Hu C; Feng J; Li X
PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009508. PubMed ID: 34237073
[TBL] [Abstract][Full Text] [Related]
20. Determination of Interleukin 27-Producing CD4(+) and CD8(+) T Cells for The Differentiation Between Tuberculous and Malignant Pleural Effusions.
Liu YL; Wu YB; Zhai K; Wang XJ; Shi HZ
Sci Rep; 2016 Jan; 6():19424. PubMed ID: 26783266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
